The stock of Amphenol Corporation (NYSE:APH) increased by $0.06 on Tuesday to finish at $86.29, up 0.07 percent. The last five days have seen an average of 2,220,880 shares of common stock traded. 16 times new highs were reached in the current year, with a gain of $10.15. The average number of shares traded over the last 20 days was 1,934,785, while the average volume over the last 50 days totaled 2,177,370.
APH stock appreciated 1.24% since last month. On 08/21/23, the company’s shares reached a one-month low of $84.94. The stock touched a high of $90.28 on 07/27/23, after rallying from a low of $65.21 in 52 weeks. The price of APH stock has risen by 13.33% or $10.15 this year, reaching a new high 16 times. Still, the stock price is down -4.42% from the 52-week high.
Insider Transactions
APH stock investors should be aware that Amphenol Corporation (APH) stock had its last reported insider trading activity 20 days ago on Aug 31. On Aug 31, President, ISS Division Gavelle Jean-Luc sold 176,186 shares at $88.24 each. This transaction resulted in the insider making $15,547,023. On Aug 31, Doherty William J sold 50,000 shares at a price of US$88.57. After the transaction, the insider now owns 0 shares. President & CEO NORWITT RICHARD ADAM had earlier sold 650,000 shares on Jul 28 for $87.43 a share. The transaction was completed for $56,831,710.
Valuation Metrics
Amphenol Corporation (APH) has a trailing price-to-earnings (P/E) ratio of 28.07. Beta for the stock is 1.25. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 4.13, the price-to-book (PB) ratio of 6.83, and the price-to-cash flow ratio of 26.74.
Company paid $0.21 per share in dividends, remained unchanged from $0.21 last year. A $0.01 dividend increase was reported on Tuesday October 25 2022.
Financial Health
For the three months ended June 29, Amphenol Corporation’s quick ratio was 1.60, while its current ratio was 2.30, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 0.53, and the total debt to equity ratio is 0.57. As far as profitability goes, gross margin for the trailing twelve months is 32.10% percent. Amphenol Corporation’s EBITDA margin for the year ended June 29 was 23.77%, whereas its operating margin stood at 20.40% for the same period. Based on annual data, it had gross profit of $4.03 billion and revenue of $12.62 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. APH’s return on assets (ROA) during the last 12 months has been 12.50%. There was a 17.60% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 26.80%.
Earnings Surprise
According to Amphenol Corporation’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $3.05 billion, while revenues fell by -2.71% to $2.97 billion. It was predicted that Amphenol Corporation’s quarterly earnings would be $0.72, but it ended up being $0.68, beating the consensus by 5.90%. EBITDA was $714.0 million for the quarter. At the end of Amphenol Corporation’s most recent quarter ended June 29, its liabilities totaled 7.67 billion, while its total debt was $4.32 billion. Equity owned by shareholders amounts to $596.45 million.
Technical Picture
Here’s a quick look at Amphenol Corporation’s (APH) price momentum from a technical perspective. As of 19 September, the RSI 9-day stood at 44.86%, suggesting the stock is Neutral, with a 10.66% historical volatility rate.
The stochastic %K and %D were 22.86% and 24.94% respectively, while the average true range (ATR) was 1.12. Based on the 14-day stochastic reading of 28.31%, the RSI (14) reading is 47.49%. On the 9-day MACD Oscillator, the stock is at -0.25, and the 14-day reading is at -0.93.
Analyst Ratings
Amphenol Corporation (NYSE: APH) was downgraded by Credit Suisse to a a Neutral rating in its latest research report. The stock was previously rated as a an Outperform. Analysts have assigned Amphenol Corporation (APH) an Overweight rating. APH is a stock that is recommended for selling by 0 brokerage firms, while 7 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 1 rate it overweight and 7 others recommend it as a buy.
What is APH’s price target for the next 12 months?
The current consensus forecast for the stock is between $75.00 and $103.00, with a median target price of $96.40. In analyzing these forecasts, the average price target given by analysts for Amphenol Corporation (APH) is $95.49.
